NEUROGEN CORPORATION REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • April 14th, 2008 • Warburg Pincus Private Equity Viii L P • Pharmaceutical preparations • New York
This REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made as of April 7, 2008, by and among Neurogen Corporation, a Delaware corporation (the “Company”) and each person listed on Exhibit A attached hereto (collectively, the “Investors” and each individually, an “Investor”). Capitalized terms used herein and not otherwise defined shall have the meanings ascribed to them in Section 9(q) herein.
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 14th, 2008 • Warburg Pincus Private Equity Viii L P • Pharmaceutical preparations • New York
This SECURITIES PURCHASE AGREEMENT (this “Agreement”) is dated as of April 7, 2008, by and between Neurogen Corporation, a Delaware corporation (the “Company”), and the several purchasers identified in the attached Exhibit A (individually, a “Purchaser” and collectively, the “Purchasers”).
Joint Filing AgreementJoint Filing Agreement • April 14th, 2008 • Warburg Pincus Private Equity Viii L P • Pharmaceutical preparations
The undersigned hereby agree that the Amendment No. 1 to the statement on Schedule 13D filed by the undersigned with respect to the Common Stock, Exchangeable Preferred Stock and the Warrant of Neurogen Corporation is, and any subsequent amendment thereto signed by each of the undersigned shall be, filed on behalf of each undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.
